Author

S. Fafi-Kremer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:virus· 1

Frequent Co-Authors

A. Seve· 2 shared A. Velay· 2 shared C. Planchais· 2 shared D. Planas· 2 shared D. Veyer· 2 shared E. Simon-Loriere· 2 shared F. Gallais· 2 shared F. Guivel-Benhassine· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Seve

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintMay 26, 2021

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals

D. Planas, D. Veyer, A. Baidaliuk…·O. Schwartz

This study shows that the SARS-CoV-2 B.1.617.2 variant is less sensitive to monoclonal antibodies and sera from convalescent and vaccinated individuals compared to other variants.

DOI 10.1101/2021.05.26.445838

virusexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 12, 2021

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

D. Planas, T. Bruel, L. Grzelak…·O. Schwartz

This study assesses the neutralization sensitivity of SARS-CoV-2 B.1.1.7 and B.1.351 variants compared to D614G using sera and nasal swabs, finding reduced efficacy against B.1.351 in some convalescent and vaccinated individuals.

DOI 10.1101/2021.02.12.430472

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivJun 16, 2020

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.

A. Velay, F. Gallais, I. Benotmane…·S. Fafi-Kremer

This study evaluates the performance of SARS-CoV-2 serological tools across different panels and timepoints, finding varying sensitivities and specificities with poor agreement between assays.

DOI 10.1016/j.diagmicrobio.2020.115181

humanproteomics

𝕏 PostBluesky